Stockreport

Celularity Appoints Richard J. Berman to its Board of Directors

Celularity Inc. - Class A  (CELU) 
PDF FLORHAM PARK, N.J., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative and cellular medicine company developing placental [Read more]